Documentos de Farnos O. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Área de conocimiento: "Medicina veterinaria"

Subtipo de publicación

Publisher

Veterinary Immunology and Immunopathology(2)

Clinical and Vaccine Immunology(1)

Área temáticas

Fisiología humana(2)

Comidas y servicio de mesa(1)

Ingeniería y operaciones afines(1)

Año de Publicación

Origen

Palabras Claves

Duration of protection(1)

E2 glycoprotein(1)

E2-classical swine fever virus(1)

Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats

Abstract: For vaccination against classical swine fever virus (CSFV), it is strongly desirable to induce a rap

Palabras claves:

CSFV, Duration of protection, E2 glycoprotein, Recombinant vaccines

Ávila M., Domínguez P., Farnos O., Frias M.T., Maritza Barrera, Rodriguez M.P., Sanchez O., Tait H., Toledo J.R., Vega E.

Effectiveness of the E2-classical swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats

Abstract: Subunit recombinant vaccines against classical swine fever virus (CSFV) are a promising alternative

Palabras claves:

Cortez-San Martín M., Farnos O., Maritza Barrera, Meza C.D., Parra N.C., Rivas C.I., Saavedra P.A., Salgado E.R., Sanchez O., Toledo J.R.

Human αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs

Abstract: Subunit vaccines are a suitable alternative for the control of classical swine fever. However, such

Palabras claves:

E2-CSFV, Emergency vaccine, Human interferon, Subunit vaccine

Aguero F., Farnos O., Gómez S., Maritza Barrera, Ormazabal V., Parra N.C., Rodriguez M.P., Sanchez O., Suárez L., Toledo J.R.

Thermal stress treatment does not affect the stability and protective capacity of goat milk derived E2-marker vaccine formulation against CSFV

Abstract: Classical swine fever virus produces a huge mortality in infected herds during recurrent outbreaks,

Palabras claves:

E2-classical swine fever virus, Formulation stability, Mammary gland expression, Recombinant veterinary vaccine

Aguero F., Aguilera A., Castell S., Farnos O., Figueredo J.M., Fonseca-Rodríguez O., Frias M.T., Maritza Barrera, Montesino R., Naranjo P., Prieto Y., Rodriguez M.P., Sanchez O., Toledo J.R.